Symbol="ARAV"
AssetType="Common Stock"
Name="Aravive Inc"
Description="Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases. The company is headquartered in Houston, Texas."
CIK="1513818"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="LYONDELLBASELL TOWER, 1221 MCKINNEY STREET, SUITE 3200, HOUSTON, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="80224000"
EBITDA="-72873000"
PERatio="None"
PEGRatio="None"
BookValue="-0.645"
DividendPerShare="0"
DividendYield="0"
EPS="-2.04"
RevenuePerShareTTM="0.191"
ProfitMargin="0"
OperatingMarginTTM="-7.73"
ReturnOnAssetsTTM="-0.788"
ReturnOnEquityTTM="-385.11"
RevenueTTM="9536000"
GrossProfitTTM="-57801000"
DilutedEPSTTM="-2.04"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.365"
AnalystTargetPrice="12.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="11.41"
PriceToBookRatio="7.28"
EVToRevenue="9.97"
EVToEBITDA="-1.353"
Beta="2.269"
num_52WeekHigh="2.46"
num_52WeekLow="0.58"
num_50DayMovingAverage="1.545"
num_200DayMovingAverage="1.604"
SharesOutstanding="59869000"
DividendDate="2018-10-16"
ExDividendDate="None"
symbol="ARAV"
open="1.41"
high="1.43"
low="1.33"
price="1.34"
volume="317380.00"
latest_trading_day="2023-07-27"
previous_close="1.42"
change="-0.08"
change_percent="-5.6338%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="65"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="35"
Volume_recent_avg="305815"
Change_recent_avg="-0.02"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.4"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="35"
Aroon_momentum_negative="65"
image_negative_thumbnail_id_1="1164"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0198.jpeg"
image_negative_thumbnail_id_2="96"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0080.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="672"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_positive_thumbnail_id_2="966"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0128.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
